Ostrum Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
5,678
+586
| +12% | +$308K | 0.14% | 134 |
|
|
2025
Q1 | $3.23M | Buy |
5,092
+1,579
| +45% | +$1M | 0.17% | 111 |
|
|
2024
Q4 | $2.5M | Sell |
3,513
-584
| -14% | -$416K | 0.22% | 145 |
|
|
2024
Q3 | $4.31M | Sell |
4,097
-925
| -18% | -$972K | 0.36% | 57 |
|
|
2024
Q2 | $5.28M | Buy |
5,022
+1,563
| +45% | +$1.64M | 0.46% | 37 |
|
|
2024
Q1 | $3.33M | Sell |
3,459
-143
| -4% | -$138K | 0.26% | 108 |
|
|
2023
Q4 | $3.16M | Buy |
3,602
+842
| +31% | +$740K | 0.28% | 110 |
|
|
2023
Q3 | $2.27M | Sell |
2,760
-2,453
| -47% | -$2.02M | 0.21% | 154 |
|
|
2023
Q2 | $3.75M | Sell |
5,213
-72
| -1% | -$51.7K | 0.31% | 87 |
|
|
2023
Q1 | $4.34M | Buy |
+5,285
| New | +$4.34M | 0.38% | 65 |
|